| abstract |
The present invention describes novel C17-heteroaryl oleanolic acid derivatives, including those of the formula (1), wherein the variables are defined in the present invention. Pharmaceutical compositions, equipment and articles of manufacture comprising said compounds are also provided. Useful methods and intermediates are also provided for making the compounds, and methods for using the compounds, for example, as antioxidant inflammation modulators and compositions. |